{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:13:07Z","timestamp":1759331587227,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T00:00:00Z","timestamp":1635033600000},"content-version":"am","delay-in-days":357,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jfo.2020.07.001","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T21:40:54Z","timestamp":1601329254000},"page":"920-928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Int\u00e9r\u00eat des chambres d\u2019exposition environnementale dans l\u2019\u00e9valuation des conjonctivites allergiques"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7424-9699","authenticated-orcid":false,"given":"M.","family":"Ehret","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Bourcier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Domis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gherasim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Speeg-Schatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"de Blay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2013","author":"Mortemousque","series-title":"Conjonctivites allergiques","key":"10.1016\/j.jfo.2020.07.001_bib0165"},{"year":"2008","author":"Mortemousque","series-title":"Le test de provocation conjonctival\u00a0?\u00a0: recommandations pratiques pour le diagnostic des conjonctivites allergiques","key":"10.1016\/j.jfo.2020.07.001_bib0170"},{"key":"10.1016\/j.jfo.2020.07.001_bib0175","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archopht.1990.01070030090035","article-title":"Conjunctival allergen challenge: a clinical approach to studying allergic conjunctivitis","volume":"108","author":"Abelson","year":"1990","journal-title":"Arch Ophthalmol"},{"year":"2019","author":"Research for DE and C.","series-title":"Allergic rhinitis: developing drug products for treatment guidance for industry","key":"10.1016\/j.jfo.2020.07.001_bib0180"},{"key":"10.1016\/j.jfo.2020.07.001_bib0185","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1081-1206(10)63104-3","article-title":"Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis","volume":"79","author":"Day","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jfo.2020.07.001_bib0190","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/all.13133","article-title":"Allergen exposure chambers: harmonising current concepts and projecting the needs for the future\u2013an EAACI Position Paper","volume":"72","author":"Pfaar","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jfo.2020.07.001_bib0195","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/02770903.2018.1563902","article-title":"Validation of Strasbourg environmental exposure chamber (EEC) ALYATEC\u00ae in mite allergic subjects with asthma","volume":"57","author":"Khayath","year":"2020","journal-title":"J Asthma"},{"key":"10.1016\/j.jfo.2020.07.001_bib0200","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/cea.13511","article-title":"Efficacy of air cleaners in asthmatics allergic to cat in ALYATEC\u00ae environmental exposure chamber","volume":"50","author":"Gherasim","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jfo.2020.07.001_bib0205","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/all.12383","article-title":"Recommendations for the standardisation of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper","volume":"69","author":"Pfaar","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jfo.2020.07.001_bib0210","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/all.12986","article-title":"Conjunctival allergen provocation test?: guidelines for daily practice","volume":"72","author":"Fauquert","year":"2017","journal-title":"Allergy"},{"year":"2018","author":"European Medicines Agency.","series-title":"Clinical development of products for specific immunotherapy: the treatment allergic diseases","key":"10.1016\/j.jfo.2020.07.001_bib0215"},{"key":"10.1016\/j.jfo.2020.07.001_bib0220","first-page":"16","article-title":"Allergic rhinitis: developing drug products for treatment guidance for industry","author":"Food and Drug Administration","year":"2018","journal-title":"Allergic Rhinitis"},{"key":"10.1016\/j.jfo.2020.07.001_bib0225","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2222.1991.tb00807.x","article-title":"Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis","volume":"21","author":"Juniper","year":"1991","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jfo.2020.07.001_bib0230","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1046\/j.1365-2222.2000.00668.x","article-title":"Development and validation of the Mini Rhinoconjunctivitis Quality of Life Questionnaire","volume":"30","author":"Thompson","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jfo.2020.07.001_bib0235","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0091-6749(98)70380-X","article-title":"Measuring quality of life in children with rhinoconjunctivitis","volume":"101","author":"Juniper","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jfo.2020.07.001_bib0240","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0091-6749(94)90349-2","article-title":"Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials","volume":"93","author":"Juniper","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jfo.2020.07.001_bib0245","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jaci.2009.02.033","article-title":"Change in visual analog scale score in a pragmatic randomised cluster trial of allergic rhinitis","volume":"123","author":"Bousquet","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jfo.2020.07.001_bib0250","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/cea.12121","article-title":"Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis","volume":"43","author":"Demoly","year":"2013","journal-title":"Clin Exp Allergy"},{"year":"2008","author":"European Medicines Agency","series-title":"Guideline on the Clinical Development of Products for Specific Immunotherapy for the Treatment of Allergic Diseases","key":"10.1016\/j.jfo.2020.07.001_bib0255"},{"key":"10.1016\/j.jfo.2020.07.001_bib0260","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/pai.12561","article-title":"Comparison of outcome measures in allergic rhinitis in children, adolescents and adults","volume":"27","author":"Devillier","year":"2016","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jfo.2020.07.001_bib0265","doi-asserted-by":"crossref","first-page":"1494e6","DOI":"10.1016\/j.jaci.2014.12.1911","article-title":"Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber","volume":"135","author":"Nolte","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jfo.2020.07.001_bib0270","doi-asserted-by":"crossref","first-page":"495e2","DOI":"10.1016\/j.anai.2018.02.003","article-title":"Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unit","volume":"120","author":"Ellis","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jfo.2020.07.001_bib0275","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00044011-200323050-00003","article-title":"Onset and duration of action of ketotifen 0.025\u00a0and emedastine 0.05\u00a0% in seasonal allergic conjunctivitis: efficacy after repeated pollen challenges in the Vienna Challenge Chamber","volume":"23","author":"Horak","year":"2003","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jfo.2020.07.001_bib0280","doi-asserted-by":"crossref","first-page":"86e2","DOI":"10.1016\/j.anai.2016.10.023","article-title":"Redness response phenotypes of allergic conjunctivitis in an allergen challenge chamber","volume":"118","author":"Jacobs","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jfo.2020.07.001_bib0285","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ophtha.2013.08.007","article-title":"Effectiveness of non-pharmacologic treatments for acute seasonal allergic conjunctivitis","volume":"121","author":"Bilkhu","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2020.07.001_bib0290","first-page":"145","article-title":"A phase 2\u00a0exploratory study of a novel interleukin-1\u00a0receptor inhibitor (EBI-005) in the treatment of moderate-to-severe allergic conjunctivitis: eye & contact lens","volume":"41","author":"Goldstein","year":"2015","journal-title":"Sci Clin Pract"},{"key":"10.1016\/j.jfo.2020.07.001_bib0295","doi-asserted-by":"crossref","first-page":"122e8","DOI":"10.1016\/j.jaci.2012.03.031","article-title":"Responses to ragweed pollen in a pollen challenge chamber versus seasonal exposure identify allergic rhinoconjunctivitis endotypes","volume":"130","author":"Jacobs","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jfo.2020.07.001_bib0300","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/OPTH.S38732","article-title":"Exacerbation of signs and symptoms of allergic conjunctivitis by a controlled adverse environment challenge in subjects with a history of dry eye and ocular allergy","volume":"7","author":"Gomes","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jfo.2020.07.001_bib0305","first-page":"169","article-title":"Effect of humidity variations in a controlled environment chamber on tear evaporation after dry eye therapy: eye & contact lens","volume":"39","author":"Madden","year":"2013","journal-title":"Sci Clin Pract"},{"key":"10.1016\/j.jfo.2020.07.001_bib0310","first-page":"S1","article-title":"Clinical practice guideline: allergic rhinitis","volume":"152","author":"Seidman","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jfo.2020.07.001_bib0315","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(06)69283-0","article-title":"Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys","volume":"368","author":"Asher","year":"2006","journal-title":"Lancet (Lond Engl)"},{"key":"10.1016\/j.jfo.2020.07.001_bib0160","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/ACI.0000000000000204","article-title":"Epidemiology of allergic conjunctivitis","volume":"15","author":"Leonardi","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551220303958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551220303958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:13:45Z","timestamp":1759259625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551220303958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0181551220303958"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2020.07.001","relation":{},"ISSN":["0181-5512"],"issn-type":[{"type":"print","value":"0181-5512"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Int\u00e9r\u00eat des chambres d\u2019exposition environnementale dans l\u2019\u00e9valuation des conjonctivites allergiques","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2020.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}